Structured evidence table for Spirulina Blood Lipids Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Spirulina Blood Lipids Randomized Trial | Astaxanthin derived fromhas attracted considerable attention due to its potent antioxidant capacity; however, evidence regarding its effects on exercise performance and recovery remains inconsistent [,]. | 1 | Wei Yan (2026) | The Effects of Seaweed and Microalgae Supplementation on Exercise Performance and Recovery: A Systematic Review and Meta-Analysis |
| Spirulina Blood Lipids Randomized Trial | By integrating available evidence, this study sought to evaluate the dual effects of algae supplementation on exercise performance and recovery, identify intervention characteristics associated with greater efficacy, and provide more targeted evidence for sports nutrition practice, and guide the design of future high-quality RCTs. | 1 | Wei Yan (2026) | The Effects of Seaweed and Microalgae Supplementation on Exercise Performance and Recovery: A Systematic Review and Meta-Analysis |
| Spirulina Blood Lipids Randomized Trial | To ensure transparency, we note that, prior to data synthesis, we expanded the list of exploratory outcomes to include metabolic and oxidative stress markers, and adjusted the database search dates to ensure comprehensive coverage of the most recent clinical evidence through June 2025. | 1 | Wei Yan (2026) | The Effects of Seaweed and Microalgae Supplementation on Exercise Performance and Recovery: A Systematic Review and Meta-Analysis |
| Spirulina Blood Lipids Randomized Trial | Haematococcus pluvialis 1 2 3 4 Seaweeds (macroalgae, including brown, red, and green algae) and microalgae (e.g., Spirulina, Chlorella,) are rich sources of high-quality protein, essential amino acids, B vitamins, and trace elements such as iron and magnesium []. | 1 | Wei Yan (2026) | The Effects of Seaweed and Microalgae Supplementation on Exercise Performance and Recovery: A Systematic Review and Meta-Analysis |
| Spirulina Blood Lipids Randomized Trial | Chlorella 5 7 8 9 10 Emerging evidence suggests that supplementation withand spirulina may be associated with improvements in metabolic parameters such as insulin sensitivity, lipid profiles, and hepatic steatosis markers while simultaneously reducing systemic inflammatory burden and oxidative stress. | 3 | Rzeski Wojciech (2026) | Chlorella and Arthrospira (Spirulina) as Multi-Pathway Biological Response Modulators: Molecular Mechanisms, Signaling Pathways and Clinical Evidence |
| Spirulina Blood Lipids Randomized Trial | We also discuss clinical evidence, safety considerations, and translational perspectives, highlighting current knowledge gaps and future research directions necessary for the rational development of microalgae-based interventions in preventive and integrative medicine. | 3 | Rzeski Wojciech (2026) | Chlorella and Arthrospira (Spirulina) as Multi-Pathway Biological Response Modulators: Molecular Mechanisms, Signaling Pathways and Clinical Evidence |
| Spirulina Blood Lipids Randomized Trial | 2 7 19 In spirulina, phycobiliproteins, particularly phycocyanin, are the dominant pigment-derived bioactives, with documented antioxidant and anti-inflammatory activity and emerging evidence for metabolic signaling effects including Nrf2 activation and the attenuation of oxidative stress in preclinical models [,,]. | 3 | Rzeski Wojciech (2026) | Chlorella and Arthrospira (Spirulina) as Multi-Pathway Biological Response Modulators: Molecular Mechanisms, Signaling Pathways and Clinical Evidence |
| Spirulina Blood Lipids Randomized Trial | Chlorella Arthrospira Microalgae represent a diverse group of aquatic photosynthetic microorganisms and a rich source of bioactive compounds with significant potential in functional foods, nutraceuticals, and preventive medicine. | 3 | Rzeski Wojciech (2026) | Chlorella and Arthrospira (Spirulina) as Multi-Pathway Biological Response Modulators: Molecular Mechanisms, Signaling Pathways and Clinical Evidence |
Source documents